Navigation Links
HCA Reports First Quarter 2009 Results
Date:4/27/2009

first quarter of 2009 include losses on sales of facilities of $5 million compared to gains of $51 million in the first quarter of 2008. First quarter 2009 results also include a $9 million charge for impairment of long-lived assets.

"We are pleased with the results of our first quarter. We believe these results reflect effective cost management, focused growth strategies, and a continued emphasis on our outcomes-driven patient care initiatives," said Richard M. Bracken, HCA's president and chief executive officer.

The provision for doubtful accounts decreased to $807 million, or 10.9 percent of revenues, in the first quarter of 2009 from $888 million, or 12.5 percent of revenues, in the first quarter of 2008, primarily due to a small decline in uninsured admissions and increased levels of charity care and uninsured discounts which reduces the Company's reported revenues. Same facility uninsured admissions declined 0.1 percent in the first quarter of 2009 compared to the prior year's first quarter. Same facility charity care and uninsured discounts totaled $1.082 billion in the first quarter of 2009 compared to $780 million in the first quarter of 2008.

During the first quarter of 2009, salaries and benefits, supply expense and other operating expenses totaled $5.235 billion compared to $5.126 billion in the first quarter of 2008, a decline of 1.4 percent, as a percent of revenues.

Interest expense decreased to $471 million in the first quarter of 2009, compared to $530 million in the same period of 2008, due primarily to a reduction in the average interest rate on our outstanding debt.

Same facility admissions declined 0.9 percent and same facility equivalent admissions increased 1.9 percent in the first quarter of 2009 compared to the prior year's first quarter. Same facility inpatient surgeries declined 0.5 percent and outpatient surgeries declined 0.7 percent in the first q
'/>"/>

SOURCE HCA Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Recent Study Disproves General Hospitals Ongoing Criticism of Physician Owned Hospitals, Shows Little to No Effect on General Hospitals Business, Reports Physician Hospitals of America
2. Neovasc Inc. Reports Year 2008 Financial Results
3. NBTY Reports Second Quarter Results
4. Statement from USPA Exec. Dir. on News Reports of Florida Pharmacy Admission of Error in the Medicine Dispensed to the Horses Who Died on Sunday
5. Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65.
6. Pharmacyclics Reports Third Quarter Fiscal 2009 Financial Results
7. NeoGenomics, Inc. Reports First Quarter 2009 Financial Results
8. Zimmer Holdings, Inc. Reports First Quarter 2009 Financial Results
9. CuraGen Reports First Quarter 2009 Financial Results
10. NuVasive Reports First Quarter 2009 Financial Results
11. Torchmark Corporation Reports First Quarter 2009 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...re shortly after birth to ambient metals from resi...diesel emissions are associated with respiratory s... a new study by researchers at the Columbia Center...lumbia University,s Mailman School of Public Healt...of exposure to airborne metals in this very young ...
(Date:11/23/2009)...co is proud to announce its participation in the 2...ighest grade possible amongst all major CR vendors...dquo;A” in sales, service and technology fie...oftware functionality. iCRco is very pleased to ha...restigious research firm in medical imaging, KLAS....
(Date:11/23/2009)...re/--James.G.Schwade,M.D.announcesthenewlyenhanced...CyberKnifeCenterofMiami,( www.cyberknifemiami.com...selytargetedintensedoseofradiationthatkillscancerc...reatmentcanlastfrom30minutestoonehour,andisusually...feTreatmentCenterintheSoutheasternU.S.,theMiamifac...
(Date:11/23/2009)...d within one year of starting to have sex, CDC rep...News) -- As many as one in four U.S. teenage girls...ny infected soon after their first sexual encounte...urden of STDs among teen girls reminds us that we ...Gottlieb, from the division of sexually transmitte...
(Date:11/23/2009)...College of Georgia is leading an initiative that c...ients with sickle cell disease. , Morehouse Uni...da are partners in the initiative that is enlistin...as "medical homes" for patients, changing how pati...the hospital and seeking better prevention and tre...
Breaking Medicine News(10 mins):Health News:Exposures to metals and diesel emissions in air linked to respiratory symptoms in children 2Health News:iCRco is the Only CR Vendor to Receive the Highest Grade “A” in All Fields by KLAS 2Health News:iCRco is the Only CR Vendor to Receive the Highest Grade “A” in All Fields by KLAS 3Health News:One in Four Teen Girls Have STDs 2Health News:One in Four Teen Girls Have STDs 3Health News:Initiative could result in paradigm shift in the care of sickle cell patients 2Health News:Initiative could result in paradigm shift in the care of sickle cell patients 3Health News:Initiative could result in paradigm shift in the care of sickle cell patients 4Health News:Initiative could result in paradigm shift in the care of sickle cell patients 5
...arma.com Toronto Stock Exchange Symbol: AKL, MON...ma Inc. (TSX:,"AKL"), a drug development company f...and pain markets, today announced that it has star...ces., This Phase I trial for the first EDACS(TM) ...
...d Jenkinson in the Department of Oral & Dental Sci...has been awarded a grant of 285,000 from The Wellc...ed by Streptococcus bacteria. , Familiar to thos...ms, some mild, some life-threatening, ranging from...
..., March 5 The following is a,statement in respons...c,cancer from Julie Fleshman, President and CEO of...tional organization creating hope in a,comprehensi...th,pancreatic cancer and our thoughts go out to hi...
...ARK, N.J., March 5 Besler,& Company, Inc., a heal...Besler, have agreed to pay the United States $2.87...fraud against the federal Medicare program, the,Ju... to improperly,increase charges to Medicare patien...
... 5 As two of the state,s leading,health groups th... Freedom,to Breathe Act, we are pleased that the M...ed so-called "theatrical performances" in bars as ...and smoke. So-called "theatrical,performances" in ...
...h 5 Every woman could use,a little pampering now ...d,to celebrate her survivorship? Let the Pennsylva...f Ephrata take care of everything!, All you have ...ur mom could be in for a real treat! Salon Art,Tif...
Other Medicine News:Health News:Akela Pharma initiates its first abuse deterrent opioid Phase I clinical trial 2Health News:New research from the University of Bristol aims to eliminate Streptococcus infections 2Health News:Patrick Swayze's Diagnosis With Pancreatic Cancer: a Statement From the Pancreatic Cancer Action Network 2Health News:New Jersey Healthcare Consulting Firm to Pay U.S. $2.875 Million to Resolve Allegations of Medicare Fraud 2Health News:Leading Health Groups Strongly Support the Minnesota Department of Health's Efforts to Enforce Freedom to Breathe Act 2Health News:The Pennsylvania Breast Cancer Coalition Announces Last Chance to Enter 'Makeover for Mom' Contest 2
(Date:11/23/2009)...--Reportlinker.comannouncesthatanewmarketresearchr...oringSystems-AGlobalMarketReview ,, http://w...tems---A-Global-Market-Review.html#utm_source=prne...re ,, Cardiovascularmonitoringisextremelybe...becontinuouslymonitoredduringdiagnosticaswellaspat...
(Date:11/23/2009)...wswire/--LightSciencesOncology,Inc.(LSO)todayannou...lekta,toanewlycreatedseatonitsboardofdirectors.Mr....uctcompanies,includingElekta,tomarketleadership. ,...strengthinbusinessdevelopmenttotheboard,"saidLSO,s...eaderincancer-therapybusinessdevelopment.Hehasover...
(Date:11/23/2009)...RNewswire/--Sarnova,Inc.,thenation,sleadingspecial...icalservices(EMS)andrespiratorymarkets,announcedto...gementteam.ThenewexecutivesincludeTomDavid,executi...identandgeneralcounsel;SteveLacke,executivevicepre...residentofcorporatedevelopment. ,, "Ihaveworked...
Breaking Medicine Technology:Reportlinker Adds Holter Monitoring Systems - A Global Market Review 2Reportlinker Adds Holter Monitoring Systems - A Global Market Review 3Reportlinker Adds Holter Monitoring Systems - A Global Market Review 4Reportlinker Adds Holter Monitoring Systems - A Global Market Review 5Light Sciences Oncology Elects Akbar Seddigh, Chairman of Elekta AB to Its Board of Directors 2Sarnova Expands Senior Management Team 2Image guided treatment for deep venous thrombosis could improve patients long term outcomes 57722 1Image guided treatment for deep venous thrombosis could improve patients long term outcomes 57722 2Surgeon Battling Own Cancer Developed New Treatment 57718 1Surgeon Battling Own Cancer Developed New Treatment 57718 2Surgeon Battling Own Cancer Developed New Treatment 57718 3Scientists discover key factor in regulating placenta and fetal growth 9988 1Scientists discover key factor in regulating placenta and fetal growth 9988 2
...se 1 Clinical Trial of SNS-595 in Acute,Leukemia D...N FRANCISCO, Calif., June 11, 2007,/PRNewswire-Fir...,positive data from clinical studies of two of the... and SNS-032, at the 12th,Congress of the European..., Interim Results from Sunesis, Phase 1 Study of S...
... 2007 (MARKET WIRE via COMTEX News Network),-- End...of Endo,Pharmaceuticals Holdings Inc. (NASDAQ: END...zed, double-blind, placebo-controlled,clinical tri...g,tablets as a six-day preventative treatment in w...M). The data demonstrated,that FROVA significantly...
Other Medicine Technology:Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 2Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 3Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 4Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 5Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 6Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 2Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 3Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 4Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 5Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 6Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 7
Eftiar®-Decalin
DOVER Red Rubber Robinson Catheters (Latex)
DOVER Silver Foley Catheter 3-way
KENGUARD Silicone-Coated Foley Catheter 2-Way
Medicine Products: